BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,081 filers reported holding BAXTER INTL INC in Q1 2019. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $92,000 | +24.3% | 1,128 | 0.0% | 0.01% | +22.2% |
| Q4 2018 | $74,000 | -27.5% | 1,128 | -15.1% | 0.01% | -18.2% |
| Q3 2018 | $102,000 | +21.4% | 1,328 | +17.7% | 0.01% | +22.2% |
| Q2 2018 | $84,000 | -14.3% | 1,128 | -25.0% | 0.01% | -18.2% |
| Q1 2018 | $98,000 | +16.7% | 1,503 | +15.3% | 0.01% | +22.2% |
| Q4 2017 | $84,000 | +2.4% | 1,303 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $82,000 | +3.8% | 1,303 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $79,000 | +17.9% | 1,303 | 0.0% | 0.01% | +12.5% |
| Q1 2017 | $67,000 | +17.5% | 1,303 | 0.0% | 0.01% | +33.3% |
| Q4 2016 | $57,000 | -8.1% | 1,303 | 0.0% | 0.01% | -14.3% |
| Q3 2016 | $62,000 | +5.1% | 1,303 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $59,000 | -14.5% | 1,303 | -22.3% | 0.01% | -12.5% |
| Q1 2016 | $69,000 | +3.0% | 1,678 | -3.9% | 0.01% | 0.0% |
| Q4 2015 | $67,000 | +15.5% | 1,746 | 0.0% | 0.01% | +14.3% |
| Q3 2015 | $58,000 | -52.5% | 1,746 | 0.0% | 0.01% | -53.3% |
| Q2 2015 | $122,000 | -14.7% | 1,746 | -16.1% | 0.02% | -16.7% |
| Q1 2015 | $143,000 | -39.7% | 2,082 | -35.6% | 0.02% | -35.7% |
| Q4 2014 | $237,000 | -53.5% | 3,232 | -54.2% | 0.03% | -12.5% |
| Q3 2014 | $510,000 | +88.9% | 7,064 | +89.3% | 0.03% | -5.9% |
| Q2 2014 | $270,000 | +37.1% | 3,732 | +39.1% | 0.03% | +25.9% |
| Q1 2014 | $197,000 | -11.3% | 2,682 | -15.7% | 0.03% | -12.9% |
| Q4 2013 | $222,000 | +212.7% | 3,182 | +194.1% | 0.03% | +181.8% |
| Q3 2013 | $71,000 | -26.8% | 1,082 | -22.4% | 0.01% | -26.7% |
| Q2 2013 | $97,000 | – | 1,394 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |